article thumbnail

White paper recommends expanding endoscopic classification of esophagogastric junction integrity beyond hill grade

Medical Xpress

A new white paper by the American Foregut Society recommends expanding the classification of the esophagogastric junction (EGJ) to increase an assessment of the axial hiatal hernia length, hiatal hernia aperture diameter, and presence or absence of the flap value, making it more comprehensive.

Medical 75
article thumbnail

New white paper finds Medicare coverage for weight loss therapies could generate significant cost-offsets

Medical Xpress

A new USC Schaeffer Center white paper finds the value to society of Medicare coverage for new classes of weight loss drugs would equal nearly $1 trillion over ten years.

70
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New white paper offers solutions to ensure greater patient access to prescription drugs

Medical Xpress

Although the Inflation Reduction Act of 2022 (IRA) aimed to increase patient access to prescription drugs and decrease spending, researchers warn that it may have unintended negative impacts on patients in the long run.

article thumbnail

Increasing cyber and ethical risks to safety means care homes' need for insurance protection is greater than ever

Medical Xpress

The cyber and ethical risks posed by telemedicine to care homes could outweigh its value unless safeguarding steps are taken, says a new white paper.

article thumbnail

Beware the bait-and-switch when it comes to HM program contracts

Sound Physicians

Compared with industry-standard annual subsidy increases of between 4.2 percent and 5.7 percent, our average increase over five years is just 0.5 percent annually.

IT 52
article thumbnail

OPQ’s 2023 Annual Report: an Upbeat Review of CDER’s Quality Efforts

FDA Law Blog

It also noted that last year, FDA hosted a two-day public workshop and published a white paper on the regulatory framework for Artificial Intelligence in drug manufacturing, in addition to other efforts. Like many of us, OPQ seems intent on trying to keep up with how technology can/will impact pharmaceutical quality.

article thumbnail

Avoid CMC Challenges by Thinking Slow, Not Fast-Discussions at USP’s Workshop

FDA Law Blog

Stay tuned for USP white paper(s) on the workshop’s discussion as well as USP information chapters on lenti-viral vector cell therapies. Overall, it appeared from the workshop discussions that potential standards relevant to CART cell therapies include particle size, particle number, for the cell line, and infectious titers.